← 產業報告目錄

Latin America Infusion Pump Market by Product (Accessories & Consumables, Devices (Volumetric, Insulin, Syringe, Ambulatory, PCA)), Application (Chemotherapy, Diabetes, Analgesia, Pediatrics, Hematology), End User (Hospitals) - Global Forecast to 2030

出版商 MarketsandMarkets產業別 Medical Devices出版日期 2025-09-16頁數 297報告編號 MD4587

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The Latin America infusion pumps market is projected to reach USD 1.00 billion by 2030 from USD 0.74 billion in 2025, at a CAGR of 6.2% during the forecast period. The infusion pumps market in Latin America is growing steadily, supported by factors such as rising chronic diseases, changing demographics, and better healthcare facilities. Conditions like diabetes, cancer, and cardiovascular disorders are becoming more common in the region and often require precise and continuous delivery of medicines. Infusion pumps help doctors provide accurate treatment, especially for patients who need long-term care. The growing elderly population also adds to this demand, as older people usually need frequent and controlled drug administration. Along with this, the increasing need for oncology and critical care therapies makes infusion pumps essential for hospitals and clinics across Latin America. By product, the accessories & consumables segment accounted for the largest share of the market in 2024. By product, the Latin America infusion pumps market has been segmented into accessories & consumables and devices. The accessories & consumables segment accounted for the largest share of the infusion pumps market in 2024. The accessories & consumables segment is driven by the growing installed base of infusion pumps and the recurring need for disposables like IV sets, catheters, and tubing. The rise in long-term therapies and hospital admissions also increases demand for regular replacement and maintenance components. By product (devices), the volumetric infusion pumps segment accounted for the largest market share in 2024. Based on devices, the Latin America infusion pumps market is segmented into volumetric infusion pumps, insulin pumps, enteral infusion pumps, ambulatory infusion pumps, syringe infusion pumps, patient-controlled analgesia (PCA) pumps, and implantable infusion pumps. The volumetric infusion pumps segment accounted for the largest infusion pump devices market share in 2024. The growth of the volumetric infusion pumps segment in the LATAM market is driven by the rising prevalence of chronic diseases necessitating precise fluid administration and the expansion of healthcare infrastructure across the region. Additionally, adopting advanced infusion technologies, including smart pumps with enhanced safety features, and increased healthcare spending contribute to the segment's expansion. By application, the diabetes segment accounted for the largest share of the market in 2024. Based on application, the Latin America infusion pumps market is segmented into chemotherapy/oncology, diabetes management, gastroenterology, analgesia/pain management, pediatrics/neonatology, hematology, and other applications (includes infectious diseases, autoimmune diseases, and diseases of the heart, kidney, lung, and liver). The diabetes segment accounted for the largest market share owing to the rising prevalence of diabetes and the increasing adoption of insulin pumps for precise, continuous insulin delivery. Growing awareness of advanced diabetes management and supportive healthcare initiatives further accelerates demand. By country, Brazil accounted for the largest share of the market in 2024. The Latin America infusion pump market is divided by country, including Brazil, Mexico, Argentina, Colombia, Chile, Ecuador, Peru, and the Rest of Latin America. In 2024, Brazil accounted for the largest market share, driven by its large patient population and high prevalence of chronic diseases, fueling the demand for infusion therapies in oncology, diabetes, and critical care across leading hospital systems. The growing use of smart and ambulatory pumps, aided by advancements in hospital infrastructure and IT, accelerates adoption and replacement rates. Additionally, government and private healthcare investments and Brazil’s expansive supplementary health plans are enhancing procurement capacity and supporting standardization efforts that promote enterprise-wide infusion platforms and service agreements. A breakdown of the primary participants (supply-side) for the Latin America infusion pumps market referred to in this report is provided below: • By Company Type: Tier 1–45%, Tier 2–20%, and Tier 3–35% • By Designation: C-level–35%, Director Level–25%, and Others–40% • By Region: Brazil–40%, Mexico–25%, Argentina–20%, Colombia- 10%, and the Rest of Latin America- 5%. The key players in the Latin America infusion pumps market include are Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), Baxter International Inc. (US), Fresenius Kabi (Germany), Medtronic plc (Ireland), ICU Medical, Inc. (US), Terumo Corporation (Japan), Nipro Corporation (Japan), Avanos Medical, Inc. (US), JMS Co., Ltd. (Japan), Cardinal Health, Inc. (US), Roche Diagnostics (Switzerland), Abbott Laboratories (US), Danaher Corporation (US), Ypsomed Holding AG (Switzerland), and Tandem Diabetes Care, Inc. (US), Harvard Bioscience, Inc. (US), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), and Intuvie Holding LLC (US), among others. Research Coverage: The report analyzes the Latin America infusion pumps market and estimates the market size and future growth potential based on various segments such as devices & consumables, cancer type, procedure, end user, and region. The report also includes a competitive analysis of the key players in this market along with their company profiles, service offerings, recent developments, and key market strategies. Reasons to Buy the Report The report will help the market leaders/new entrants with information on the closest approximations of the revenue numbers for the overall Latin America infusion pumps market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities. This report provides insights into the following pointers:  Analysis of key drivers (rising incidence of diabetes, growing geriatric population and subsequent rise in chronic diseases, rising number of surgical procedures, and the increasing adoption of enteral feeding pumps due to surge in pre-term births), restraints (stringent regulatory requirements for product commercialization, increasing adoption of refurbished & rented infusion pumps), opportunities (high growth potential in emerging economies and the increasing adoption of specialty infusion systems), challenges (increasing incidence of medication errors and inadequate wireless connectivity across several hospitals)  Market Penetration: Comprehensive information on product portfolios offered by the top players in the Latin America infusion pumps market. The report analyzes this market by product, application, and end user.  Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the Latin America infusion pumps market  Market Development: Comprehensive information on the lucrative emerging markets by product, application, and end user.  Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the Latin America infusion pumps market  Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the Latin America infusion pumps market.
目錄 Table of Contents
1 INTRODUCTION 25 1.1 STUDY OBJECTIVES 25 1.2 MARKET DEFINITION 25 1.2.1 INCLUSIONS & EXCLUSIONS 26 1.2.2 MARKETS COVERED 27 1.2.3 YEARS CONSIDERED 28 1.2.4 CURRENCY CONSIDERED 28 1.3 MARKET STAKEHOLDERS 29 1.4 SUMMARY OF CHANGES 29 2 RESEARCH METHODOLOGY 31 2.1 RESEARCH APPROACH 31 2.1.1 SECONDARY DATA 31 2.1.1.1 Key data from secondary sources 32 2.1.2 PRIMARY DATA 33 2.1.2.1 Primary sources 33 2.1.2.2 Key data from primary sources 34 2.1.2.3 Breakdown of primaries 34 2.2 MARKET SIZE ESTIMATION 35 2.3 GROWTH FORECAST 40 2.4 MARKET BREAKDOWN & DATA TRIANGULATION 41 2.5 KEY INDUSTRY INSIGHTS 42 2.6 LIMITATIONS 42 2.6.1 METHODOLOGY-RELATED LIMITATIONS 42 2.7 RISK ASSESSMENT 43 2.8 STUDY ASSUMPTIONS 43 3 EXECUTIVE SUMMARY 44 4 PREMIUM INSIGHTS 53 4.1 LATAM INFUSION PUMPS MARKET OVERVIEW 53 4.2 LATAM INFUSION PUMPS MARKET, BY PRODUCT & COUNTRY, 2024 (USD MILLION) 54 4.3 LATAM INFUSION PUMPS MARKET: REGIONAL MIX 55 4.4 LATAM INFUSION PUMPS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 55 5 MARKET OVERVIEW 56 5.1 MARKET DYNAMICS 56 5.1.1 MARKET DRIVERS 57 5.1.1.1 Rising incidence of diabetes 57 5.1.1.2 Growing geriatric population and subsequent rise in chronic diseases 57 5.1.1.3 Rising number of surgical procedures 58 5.1.1.4 Increasing adoption of enteral feeding pumps due to surge in pre-term births 58 5.1.2 RESTRAINTS 59 5.1.2.1 Stringent regulatory requirements for product commercialization 59 5.1.2.2 Increasing adoption of refurbished & rented infusion pumps 59 5.1.3 OPPORTUNITIES 60 5.1.3.1 High growth potential in emerging economies 60 5.1.3.2 Increasing adoption of specialty infusion systems 60 5.1.4 CHALLENGES 60 5.1.4.1 Increasing incidence of medication errors and inadequate wireless connectivity across several hospitals 60 5.2 TECHNOLOGY ANALYSIS 61 5.2.1 KEY TECHNOLOGIES 61 5.2.1.1 Flow generation 61 5.2.1.2 Smart infusion systems 62 5.2.1.3 Closed-loop infusion control systems 62 5.2.2 COMPLEMENTARY TECHNOLOGIES 63 5.2.2.1 Dose-error reduction systems 63 5.2.2.2 Wireless connectivity 63 5.2.2.3 AI-powered decision support systems 64 5.2.3 ADJACENT TECHNOLOGIES 64 5.2.3.1 Embedded software 64 5.2.3.2 Sensing technology 64 5.3 PORTER’S FIVE FORCES ANALYSIS 65 5.3.1 THREAT OF NEW ENTRANTS 66 5.3.2 THREAT OF SUBSTITUTES 66 5.3.3 BARGAINING POWER OF SUPPLIERS 66 5.3.4 BARGAINING POWER OF BUYERS 67 5.3.5 INTENSITY OF COMPETITIVE RIVALRY 67 5.4 REGULATORY ANALYSIS 67 5.4.1 REGULATORY LANDSCAPE 67 5.4.1.1 Brazil 67 5.4.1.2 Mexico 68 5.4.1.3 Argentina 68 5.4.1.4 Colombia 68 5.4.1.5 Chile 69 5.4.1.6 Ecuador 69 5.4.1.7 Peru 69 5.4.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 70   5.5 PATENT ANALYSIS 71 5.5.1 PATENT PUBLICATION TRENDS FOR INFUSION PUMPS 71 5.5.2 INSIGHTS: JURISDICTION & TOP APPLICANT ANALYSIS 72 5.6 TRADE ANALYSIS 73 5.6.1 EXPORT DATA FOR HS CODE 901890 73 5.6.2 IMPORT DATA FOR HS CODE 901890 74 5.7 REIMBURSEMENT ANALYSIS 74 5.8 PRICING ANALYSIS 75 5.8.1 AVERAGE SELLING PRICE TREND FOR DEVICES, BY KEY PLAYER, 2022–2024 75 5.8.2 AVERAGE SELLING PRICE TREND OF INFUSION PUMPS, BY REGION, 2022–2024 76 5.9 KEY CONFERENCES & EVENTS, 2025–2026 76 5.10 KEY STAKEHOLDERS & BUYING CRITERIA 77 5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS 77 5.10.2 BUYING CRITERIA 77 5.11 IMPACT OF AI/GENERATIVE AI ON LATAM INFUSION PUMPS MARKET 78 5.11.1 INTRODUCTION 78 5.11.2 MARKET POTENTIAL IN LATAM INFUSION PUMPS ECOSYSTEM 78 5.11.3 KEY COMPANIES IMPLEMENTING AI IN INFUSION PUMPS 79 5.11.4 FUTURE OF GENERATIVE AI IN LATAM INFUSION PUMPS ECOSYSTEM 79 5.12 ECOSYSTEM ANALYSIS 80 5.13 VALUE CHAIN ANALYSIS 80 5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 82 5.15 INVESTMENT & FUNDING SCENARIO 82 5.16 TRUMP TARIFF IMPACT ON LATAM INFUSION PUMPS MARKET 83 5.16.1 INTRODUCTION 83 5.16.2 KEY TARIFF RATES 84 5.16.3 PRICE IMPACT ANALYSIS 84 5.16.4 IMPACT ON LATAM REGION 85 5.16.5 IMPACT ON END-USE INDUSTRIES 85 6 LATIN AMERICA INFUSION PUMPS MARKET, BY PRODUCT 87 6.1 INTRODUCTION 88 6.2 ACCESSORIES & CONSUMABLES 88 6.2.1 DEDICATED ACCESSORIES & CONSUMABLES 91 6.2.1.1 Volumetric infusion pump dedicated disposables 94 6.2.1.1.1 High adoption across hospitals & clinical settings to fuel uptake 94 6.2.1.2 Insulin infusion pump dedicated disposables 95 6.2.1.2.1 Rising number of insulin-dependent diabetic patients to support market growth 95 6.2.1.3 Enteral infusion pump dedicated disposables 96 6.2.1.3.1 Precision & consistency in results to fuel uptake 96 6.2.1.4 Syringe infusion pump dedicated disposables 97 6.2.1.4.1 High demand in developed countries to aid market 97 6.2.1.5 Ambulatory infusion pump dedicated disposables 99 6.2.1.5.1 Growth in home healthcare market to boost demand 99 6.2.1.6 PCA pump dedicated disposables 100 6.2.1.6.1 Increasing demand for critical pain management to boost market 100 6.2.1.7 Implantable infusion pump dedicated disposables 101 6.2.1.7.1 High compatibility with pumps to fuel uptake 101 6.2.2 NON-DEDICATED ACCESSORIES & CONSUMABLES 102 6.2.2.1 Infusion catheters 104 6.2.2.1.1 Potential for recurrent use to drive demand 104 6.2.2.2 IV administration sets 105 6.2.2.2.1 Rising demand for use in various systems to propel market 105 6.2.2.3 Needleless connectors 106 6.2.2.3.1 Reduction in bloodstream infection risks to boost demand 106 6.2.2.4 Cannulas 107 6.2.2.4.1 Ability to ease patient discomfort to boost demand 107 6.2.2.5 Tubing & extension sets 108 6.2.2.5.1 Need for continuous & efficient connections to fuel uptake 108 6.2.2.6 Valves 110 6.2.2.6.1 Improvement in quality of infusion to drive market 110 6.2.2.7 Other non-dedicated accessories & consumables 111 6.3 DEVICES 112 6.3.1 DEVICES MARKET, BY PRODUCT 113 6.3.1.1 Volumetric infusion pumps 114 6.3.1.1.1 Technological improvements to boost market 114 6.3.1.2 Insulin pumps 115 6.3.1.2.1 High demand from diabetics to propel market 115 6.3.1.3 Ambulatory infusion pumps 117 6.3.1.3.1 Rising cancer prevalence and increasing patient awareness to fuel market 117 6.3.1.4 Syringe infusion pumps 118 6.3.1.4.1 Cost-effectiveness and portability to boost demand 118 6.3.1.5 Enteral infusion pumps 120 6.3.1.5.1 Technological advancements to bolster market 120 6.3.1.6 PCA pumps 121 6.3.1.6.1 Growth in pain management to fuel uptake 121 6.3.1.7 Implantable infusion pumps 122 6.3.1.7.1 Growing use of long-term delivery of opioid medication to boost market 122   6.3.2 DEVICES MARKET, BY TECHNOLOGY 123 6.3.2.1 Traditional infusion pumps 124 6.3.2.1.1 Growing use in long-term care settings to drive demand 124 6.3.2.2 Specialty infusion pumps 125 6.3.2.2.1 Rising adoption in home care settings to drive market 125 6.3.3 DEVICES MARKET, BY TYPE 126 6.3.3.1 Stationary infusion pumps 127 6.3.3.1.1 High adoption in hospitals to drive market 127 6.3.3.2 Portable infusion pumps 128 6.3.3.2.1 Technological advancements to support market growth 128 7 LATIN AMERICA INFUSION PUMPS MARKET, BY APPLICATION 130 7.1 INTRODUCTION 131 7.2 CHEMOTHERAPY/ONCOLOGY 131 7.2.1 GROWING INCIDENCE OF CANCER TO DRIVE MARKET 131 7.3 DIABETES MANAGEMENT 133 7.3.1 RISING DEMAND FOR EFFECTIVE DIABETES TREATMENT TO BOOST MARKET 133 7.4 GASTROENTEROLOGY 135 7.4.1 GROWING UPTAKE IN GASTROINTESTINAL DISEASE TREATMENT TO FUEL MARKET 135 7.5 ANALGESIA/PAIN MANAGEMENT 137 7.5.1 RISING NUMBER OF SURGICAL PROCEDURES TO AID MARKET 137 7.6 PEDIATRICS/NEONATOLOGY 138 7.6.1 INCREASING INCIDENCE OF PEDIATRIC DIABETES TO SUPPORT MARKET GROWTH 138 7.7 HEMATOLOGY 139 7.7.1 INCREASING PREVALENCE OF BLOOD DISORDERS TO BOOST DEMAND 139 7.8 OTHER APPLICATIONS 141 8 LATIN AMERICA INFUSION PUMPS MARKET, BY END USER 143 8.1 INTRODUCTION 144 8.2 HOSPITALS 144 8.2.1 RISING INCIDENCE OF CHRONIC DISEASES AND GROWING FOCUS ON INFUSION THERAPY TO DRIVE MARKET 144 8.3 HOME CARE SETTINGS 146 8.3.1 RISING TECHNOLOGICAL ADVANCEMENTS IN PORTABLE & USER-FRIENDLY DEVICES TO PROPEL MARKET 146 8.4 AMBULATORY CARE SETTINGS 146 8.4.1 RISING NUMBER OF SURGICAL PROCEDURES TO BOOST MARKET 146 8.5 ACADEMIC & RESEARCH INSTITUTES 148 8.5.1 INCREASING MEDICAL RESEARCH ACTIVITIES TO SUPPORT MARKET GROWTH 148 8.6 ONCOLOGY CENTERS 149 8.6.1 GROWING FOCUS ON THERAPEUTICS TO FUEL UPTAKE 149 8.7 OTHER END USERS 150 9 LATIN AMERICA INFUSION PUMPS MARKET, BY COUNTRY 151 9.1 LATIN AMERICA 152 9.1.1 LATAM INFUSION PUMP DEVICES MARKET, BY PRODUCT, 2023–2030 (THOUSAND UNITS) 153 9.1.2 MACROECONOMIC OUTLOOK FOR LATAM COUNTRIES 154 9.1.3 BRAZIL 154 9.1.3.1 Increasing number of chronic conditions to drive market 154 9.1.4 MEXICO 159 9.1.4.1 Favorable government initiatives for commercialization of medical devices to boost market 159 9.1.5 ARGENTINA 164 9.1.5.1 Rapid aging population and subsequent rise in chronic diseases to boost market 164 9.1.6 COLOMBIA 169 9.1.6.1 Integration of technological advancements in hospitals & infusion therapy settings to propel market 169 9.1.7 CHILE 174 9.1.7.1 Growing focus on local infusion-therapy product manufacturers to fuel uptake 174 9.1.8 ECUADOR 178 9.1.8.1 Digital health initiatives to support market growth 178 9.1.9 PERU 183 9.1.9.1 Increasing focus on oncology therapeutics to boost market 183 9.1.10 REST OF LATIN AMERICA 187 10 COMPETITIVE LANDSCAPE 193 10.1 OVERVIEW 193 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2022–2025 193 10.3 REVENUE ANALYSIS, 2022–2024 195 10.4 MARKET SHARE ANALYSIS, 2024 195 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 197 10.5.1 STARS 198 10.5.2 EMERGING LEADERS 198 10.5.3 PERVASIVE PLAYERS 198 10.5.4 PARTICIPANTS 198 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 200 10.5.5.1 Company footprint 200 10.5.5.2 Country footprint 201 10.5.5.3 Product footprint 202 10.5.5.4 Application footprint 203   10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 204 10.6.1 PROGRESSIVE COMPANIES 204 10.6.2 RESPONSIVE COMPANIES 204 10.6.3 DYNAMIC COMPANIES 204 10.6.4 STARTING BLOCKS 204 10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 206 10.6.5.1 Detailed list of key startups/SMEs 206 10.6.6 COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 207 10.6.6.1 Competitive benchmarking of key startups/SMEs 207 10.7 R&D EXPENDITURE OF KEY PLAYERS 208 10.8 COMPANY VALUATION AND FINANCIAL METRICS 208 10.8.1 COMPANY VALUATION 208 10.8.2 FINANCIAL METRICS 209 10.9 BRAND/PRODUCT COMPARATIVE ANALYSIS 209 10.10 COMPETITIVE SCENARIO 210 10.10.1 PRODUCT LAUNCHES & APPROVALS 210 10.10.2 DEALS 211 10.10.3 EXPANSIONS 212 10.10.4 OTHER DEVELOPMENTS 213 11 COMPANY PROFILES 214 11.1 KEY PLAYERS 214 11.1.1 BECTON, DICKINSON AND COMPANY (BD) 214 11.1.1.1 Business overview 214 11.1.1.2 Products offered 215 11.1.1.3 Recent developments 218 11.1.1.3.1 Product launches & approvals 218 11.1.1.3.2 Deals 219 11.1.1.3.3 Expansions 219 11.1.1.3.4 Other developments 220 11.1.1.4 MnM view 220 11.1.1.4.1 Key strengths 220 11.1.1.4.2 Strategic choices 220 11.1.1.4.3 Weaknesses & competitive threats 220 11.1.2 B. BRAUN MELSUNGEN AG 221 11.1.2.1 Business overview 221 11.1.2.2 Products offered 222 11.1.2.3 Recent developments 227 11.1.2.3.1 Product launches & approvals 227 11.1.2.3.2 Deals 228 11.1.2.3.3 Other developments 228   11.1.2.4 MnM view 229 11.1.2.4.1 Key strengths 229 11.1.2.4.2 Strategic choices 229 11.1.2.4.3 Weaknesses & competitive threats 229 11.1.3 BAXTER INTERNATIONAL INC. 230 11.1.3.1 Business overview 230 11.1.3.2 Products offered 231 11.1.3.3 Recent developments 233 11.1.3.3.1 Product approvals 233 11.1.3.3.2 Deals 233 11.1.3.3.3 Other developments 233 11.1.3.4 MnM view 234 11.1.3.4.1 Key strengths 234 11.1.3.4.2 Strategic choices 234 11.1.3.4.3 Weaknesses & competitive threats 234 11.1.4 FRESENIUS KABI 235 11.1.4.1 Business overview 235 11.1.4.2 Products offered 236 11.1.4.3 Recent developments 239 11.1.4.3.1 Product approvals 239 11.1.4.3.2 Deals 239 11.1.4.3.3 Other developments 240 11.1.4.4 MnM view 240 11.1.4.4.1 Key strengths 240 11.1.4.4.2 Strategic choices 240 11.1.4.4.3 Weaknesses & competitive threats 241 11.1.5 MEDTRONIC 242 11.1.5.1 Business overview 242 11.1.5.2 Products offered 243 11.1.5.3 Recent developments 244 11.1.5.3.1 Product launches & approvals 244 11.1.5.3.2 Deals 245 11.1.5.4 MnM view 245 11.1.5.4.1 Key strengths 245 11.1.5.4.2 Strategic choices 246 11.1.5.4.3 Weaknesses & competitive threats 246 11.1.6 TERUMO CORPORATION 247 11.1.6.1 Business overview 247 11.1.6.2 Products offered 248 11.1.6.3 Recent developments 249 11.1.6.3.1 Product launches 249 11.1.6.3.2 Deals 250 11.1.6.3.3 Expansions 250 11.1.7 ICU MEDICAL, INC. 251 11.1.7.1 Business overview 251 11.1.7.2 Products offered 252 11.1.7.3 Recent developments 254 11.1.7.3.1 Product approvals 254 11.1.7.3.2 Deals 254 11.1.7.3.3 Other developments 254 11.1.8 AVANOS MEDICAL, INC. 255 11.1.8.1 Business overview 255 11.1.8.2 Products offered 256 11.1.9 NIPRO CORPORATION 258 11.1.9.1 Business overview 258 11.1.9.2 Products offered 259 11.1.9.3 Recent developments 260 11.1.9.3.1 Expansions 260 11.1.10 JMS CO., LTD. 261 11.1.10.1 Business overview 261 11.1.10.2 Products offered 263 11.1.11 CARDINAL HEALTH, INC. 264 11.1.11.1 Business overview 264 11.1.11.2 Products offered 266 11.1.12 ROCHE DIAGNOSTICS 267 11.1.12.1 Business overview 267 11.1.12.2 Products offered 269 11.1.12.3 Recent developments 269 11.1.12.3.1 Expansions 269 11.1.13 ABBOTT LABORATORIES 270 11.1.13.1 Business overview 270 11.1.13.2 Products offered 271 11.1.14 DANAHER CORPORATION 272 11.1.14.1 Business overview 272 11.1.14.2 Products offered 274 11.1.15 YPSOMED AG 275 11.1.15.1 Business overview 275 11.1.15.2 Products offered 276 11.2 OTHER PLAYERS 277 11.2.1 TANDEM DIABETES CARE, INC. 277 11.2.2 HARVARD BIOSCIENCE INC. 278 11.2.3 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. 279 11.2.4 INTUVIE HOLDINGS LLC 280 11.2.5 ANGIPLAST PVT. LTD. 281 11.2.6 IRADIMED CORPORATION 282 11.2.7 NEW ERA INSTRUMENTS 283 11.2.8 EPIC MEDICAL 284 11.2.9 SHENZHEN MEDRENA BIOTECH CO., LTD. 285 11.2.10 CODAN COMPANIES 285 12 APPENDIX 287 12.1 DISCUSSION GUIDE 287 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 293 12.3 CUSTOMIZATION OPTIONS 295 12.3.1 PRODUCT ANALYSIS 295 12.3.2 GEOGRAPHIC ANALYSIS 295 12.3.3 COMPANY INFORMATION 295 12.3.4 MARKET SHARE ANALYSIS 295 12.4 RELATED REPORTS 295 12.5 AUTHOR DETAILS 296
圖表清單 List of Tables & Figures
TABLE 1 LATAM INFUSION PUMPS MARKET: INCLUSIONS & EXCLUSIONS 26 TABLE 2 STANDARD CURRENCY CONVERSION RATES (USD) 28 TABLE 3 LATAM INFUSION PUMPS MARKET: RISK ASSESSMENT ANALYSIS 43 TABLE 4 LATAM INFUSION PUMPS MARKET: STUDY ASSUMPTIONS 43 TABLE 5 PORTER’S FIVE FORCES: IMPACT ANALYSIS 66 TABLE 6 LATIN AMERICA: LIST OF KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 70 TABLE 7 INFUSION PUMPS MARKET: MAJOR PATENTS 72 TABLE 8 EXPORT DATA FOR HS CODE 901890 (INCLUDING INFUSION PUMPS), BY COUNTRY, 2021–2024 (USD THOUSAND) 73 TABLE 9 IMPORT DATA FOR HS CODE 901890 (INCLUDING INFUSION PUMPS), BY COUNTRY, 2021–2024 (USD THOUSAND) 74 TABLE 10 AVERAGE SELLING PRICE TREND OF DEVICES, BY KEY PLAYER, 2022–2024 75 TABLE 11 AVERAGE SELLING PRICE TREND, LATAM REGION, 2022–2024 76 TABLE 12 LATAM INFUSION PUMPS MARKET: KEY CONFERENCES & EVENTS, 2025–2026 76 TABLE 13 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR INFUSION PUMPS (%) 77 TABLE 14 KEY COMPANIES IMPLEMENTING AI IN INFUSION PUMPS 79 TABLE 15 US-ADJUSTED RECIPROCAL TARIFF RATES 84 TABLE 16 KEY PRODUCT-RELATED TARIFF EFFECTIVE INFUSION PUMPS 84 TABLE 17 LATAM INFUSION PUMPS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 88 TABLE 18 KEY PLAYERS PROVIDING INFUSION PUMP ACCESSORIES & CONSUMABLES 89 TABLE 19 ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 91 TABLE 20 ACCESSORIES & CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 91 TABLE 21 KEY PLAYERS PROVIDING DEDICATED ACCESSORIES & CONSUMABLES 92 TABLE 22 DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 93 TABLE 23 DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 93 TABLE 24 KEY PLAYERS PROVIDING VOLUMETRIC INFUSION PUMP DEDICATED DISPOSABLES 94 TABLE 25 VOLUMETRIC INFUSION PUMP DEDICATED DISPOSABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 95 TABLE 26 KEY PLAYERS PROVIDING INSULIN INFUSION PUMP DEDICATED DISPOSABLES 96 TABLE 27 INSULIN INFUSION PUMP DEDICATED DISPOSABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 96 TABLE 28 KEY PLAYERS PROVIDING ENTERAL INFUSION PUMP DEDICATED DISPOSABLES 97 TABLE 29 ENTERAL INFUSION PUMP DEDICATED DISPOSABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 97 TABLE 30 KEY PLAYERS PROVIDING SYRINGE INFUSION PUMP DEDICATED DISPOSABLES 98 TABLE 31 SYRINGE INFUSION PUMP DEDICATED DISPOSABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 98 TABLE 32 KEY PLAYERS PROVIDING AMBULATORY INFUSION PUMP DEDICATED DISPOSABLES 99 TABLE 33 AMBULATORY INFUSION PUMP DEDICATED DISPOSABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 99 TABLE 34 KEY PLAYERS PROVIDING PCA PUMP DEDICATED DISPOSABLES 100 TABLE 35 PCA PUMP DEDICATED DISPOSABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 100 TABLE 36 KEY PLAYERS PROVIDING IMPLANTABLE INFUSION PUMP DEDICATED DISPOSABLES 101 TABLE 37 IMPLANTABLE INFUSION PUMP DEDICATED DISPOSABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 101 TABLE 38 KEY PLAYERS PROVIDING NON-DEDICATED ACCESSORIES & CONSUMABLES 102 TABLE 39 NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 103 TABLE 40 NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 103 TABLE 41 KEY PLAYERS PROVIDING INFUSION CATHETERS 104 TABLE 42 INFUSION CATHETERS NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 105 TABLE 43 KEY PLAYERS PROVIDING IV ADMINISTRATION SETS 106 TABLE 44 IV ADMINISTRATION SETS NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 106 TABLE 45 KEY PLAYERS PROVIDING NEEDLELESS CONNECTORS 107 TABLE 46 NEEDLELESS CATHETERS NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 107 TABLE 47 KEY PLAYERS PROVIDING CANNULAS 108 TABLE 48 CANNULAS NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 108 TABLE 49 KEY PLAYERS PROVIDING TUBING & EXTENSION SETS 109 TABLE 50 TUBING & EXTENSION SETS NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 109 TABLE 51 KEY PLAYERS PROVIDING VALVES 110 TABLE 52 VALVES NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 110 TABLE 53 KEY PLAYERS PROVIDING OTHER NON-DEDICATED ACCESSORIES & CONSUMABLES 111 TABLE 54 OTHER NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 111 TABLE 55 KEY PLAYERS PROVIDING INFUSION PUMP DEVICES 112 TABLE 56 LATAM INFUSION PUMPS DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 113 TABLE 57 LATAM INFUSION PUMPS DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 113 TABLE 58 KEY PLAYERS PROVIDING VOLUMETRIC INFUSION PUMPS 114 TABLE 59 VOLUMETRIC INFUSION PUMP DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 115 TABLE 60 KEY PLAYERS PROVIDING INSULIN PUMPS 116 TABLE 61 INSULIN PUMPS DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 117 TABLE 62 KEY PLAYERS PROVIDING AMBULATORY INFUSION PUMPS 117 TABLE 63 AMBULATORY INFUSION PUMP DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 118 TABLE 64 KEY PLAYERS PROVIDING SYRINGE INFUSION PUMPS 119 TABLE 65 SYRINGE INFUSION PUMP DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 119 TABLE 66 KEY PLAYERS PROVIDING ENTERAL INFUSION PUMPS 120 TABLE 67 ENTERAL INFUSION PUMP DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 121 TABLE 68 KEY PLAYERS PROVIDING PCA PUMPS 121 TABLE 69 PCA PUMP DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 122 TABLE 70 KEY PLAYERS PROVIDING IMPLANTABLE INFUSION PUMPS 123 TABLE 71 IMPLANTABLE INFUSION PUMP DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 123 TABLE 72 INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 123 TABLE 73 KEY PLAYERS PROVIDING TRADITIONAL INFUSION PUMPS 124 TABLE 74 TRADITIONAL INFUSION PUMP TECHNOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 125 TABLE 75 KEY PLAYERS PROVIDING SPECIALTY INFUSION PUMPS 126 TABLE 76 SPECIALTY INFUSION PUMP TECHNOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 126 TABLE 77 INFUSION PUMP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 127 TABLE 78 KEY PLAYERS PROVIDING STATIONARY INFUSION PUMPS 127 TABLE 79 STATIONARY INFUSION PUMP DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 128 TABLE 80 KEY PLAYERS PROVIDING PORTABLE INFUSION PUMPS 128 TABLE 81 PORTABLE INFUSION PUMP DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 129 TABLE 82 LATAM INFUSION PUMP MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 131 TABLE 83 KEY PLAYERS PROVIDING INFUSION PUMPS FOR CHEMOTHERAPY/ONCOLOGY APPLICATIONS 132 TABLE 84 LATAM INFUSION PUMPS MARKET FOR CHEMOTHERAPY/ONCOLOGY APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 133 TABLE 85 KEY PLAYERS PROVIDING INFUSION PUMPS FOR DIABETES MANAGEMENT 134 TABLE 86 LATAM INFUSION PUMPS MARKET FOR DIABETES MANAGEMENT APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 134 TABLE 87 DISEASES & DISORDERS OF DIGESTIVE SYSTEM 135 TABLE 88 KEY PLAYERS PROVIDING INFUSION PUMPS FOR GASTROENTEROLOGY APPLICATIONS 136 TABLE 89 LATAM INFUSION PUMPS MARKET FOR GASTROENTEROLOGY APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 136 TABLE 90 KEY PLAYERS PROVIDING INFUSION PUMPS FOR ANALGESIA/PAIN MANAGEMENT APPLICATIONS 137 TABLE 91 LATAM INFUSION PUMPS MARKET FOR ANALGESIA/PAIN MANAGEMENT APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 138 TABLE 92 KEY PLAYERS PROVIDING INFUSION PUMPS FOR PEDIATRICS/NEONATOLOGY APPLICATIONS 139 TABLE 93 LATAM INFUSION PUMPS MARKET FOR PEDIATRIC/NEONATOLOGY APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 139 TABLE 94 KEY PLAYERS PROVIDING LATAM INFUSION PUMPS FOR HEMATOLOGY APPLICATIONS 140 TABLE 95 LATAM INFUSION PUMPS MARKET FOR HEMATOLOGY APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 140 TABLE 96 KEY PLAYERS PROVIDING INFUSION PUMPS FOR OTHER APPLICATIONS 141 TABLE 97 LATAM INFUSION PUMPS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 142 TABLE 98 LATAM INFUSION PUMPS MARKET, BY END USER, 2023–2030 (USD MILLION) 144 TABLE 99 LATAM INFUSION PUMPS MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION) 145 TABLE 100 LATAM INFUSION PUMPS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2023–2030 (USD MILLION) 146 TABLE 101 LATAM INFUSION PUMPS MARKET FOR AMBULATORY CARE SETTINGS, BY COUNTRY, 2023–2030 (USD MILLION) 147 TABLE 102 LATAM INFUSION PUMPS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 148 TABLE 103 INFUSION PUMPS MARKET FOR ONCOLOGY CENTERS, BY COUNTRY, 2023–2030 (USD MILLION) 149 TABLE 104 INFUSION PUMPS MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 150 TABLE 105 LATAM INFUSION PUMP DEVICES MARKET, BY PRODUCT, 2023–2030 (THOUSAND UNITS) 153 TABLE 106 LATAM INFUSION PUMPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 153 TABLE 107 BRAZIL: MACROECONOMIC INDICATORS 155 TABLE 108 BRAZIL: INFUSION PUMPS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 155 TABLE 109 BRAZIL: INFUSION PUMP ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 156 TABLE 110 BRAZIL: DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 156 TABLE 111 BRAZIL: NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 157 TABLE 112 BRAZIL: INFUSION PUMP DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 157 TABLE 113 BRAZIL: INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 158 TABLE 114 BRAZIL: INFUSION PUMP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 158 TABLE 115 BRAZIL: INFUSION PUMPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 158 TABLE 116 BRAZIL: INFUSION PUMPS MARKET, BY END USER, 2023–2030 (USD MILLION) 159 TABLE 117 MEXICO: MACROECONOMIC INDICATORS 160 TABLE 118 MEXICO: INFUSION PUMPS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 160 TABLE 119 MEXICO: INFUSION PUMP ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 161 TABLE 120 MEXICO: DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 161 TABLE 121 MEXICO: NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 162 TABLE 122 MEXICO: INFUSION PUMP DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 162 TABLE 123 MEXICO: INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 163 TABLE 124 MEXICO: INFUSION PUMP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 163 TABLE 125 MEXICO: INFUSION PUMPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 163 TABLE 126 MEXICO: INFUSION PUMPS MARKET, BY END USER, 2023–2030 (USD MILLION) 164 TABLE 127 ARGENTINA: MACROECONOMIC INDICATORS 165 TABLE 128 ARGENTINA: INFUSION PUMPS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 165 TABLE 129 ARGENTINA: INFUSION PUMP ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 165 TABLE 130 ARGENTINA: DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 166 TABLE 131 ARGENTINA: NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 166 TABLE 132 ARGENTINA: INFUSION PUMP DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 167 TABLE 133 ARGENTINA: INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 167 TABLE 134 ARGENTINA: INFUSION PUMP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 168 TABLE 135 ARGENTINA: INFUSION PUMPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 168 TABLE 136 ARGENTINA: INFUSION PUMPS MARKET, BY END USER, 2023–2030 (USD MILLION) 169 TABLE 137 COLOMBIA: MACROECONOMIC INDICATORS 170 TABLE 138 COLOMBIA: INFUSION PUMPS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 170 TABLE 139 COLOMBIA: INFUSION PUMP ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 170 TABLE 140 COLOMBIA: DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 171 TABLE 141 COLOMBIA: NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 171 TABLE 142 COLOMBIA: INFUSION PUMP DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 172 TABLE 143 COLOMBIA: INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 172 TABLE 144 COLOMBIA: INFUSION PUMP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 173 TABLE 145 COLOMBIA: INFUSION PUMPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 173 TABLE 146 COLOMBIA: INFUSION PUMPS MARKET, BY END USER, 2023–2030 (USD MILLION) 174 TABLE 147 CHILE: MACROECONOMIC INDICATORS 175 TABLE 148 CHILE: INFUSION PUMPS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 175 TABLE 149 CHILE: INFUSION PUMP ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 175 TABLE 150 CHILE: DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 176 TABLE 151 CHILE: NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 176 TABLE 152 CHILE: INFUSION PUMP DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 177 TABLE 153 CHILE: INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 177 TABLE 154 CHILE: INFUSION PUMP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 177 TABLE 155 CHILE: INFUSION PUMPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 178 TABLE 156 CHILE: INFUSION PUMPS MARKET, BY END USER, 2023–2030 (USD MILLION) 178 TABLE 157 ECUADOR: MACROECONOMIC INDICATORS 179 TABLE 158 ECUADOR: INFUSION PUMPS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 179 TABLE 159 ECUADOR: INFUSION PUMP ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 180 TABLE 160 ECUADOR: DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 180 TABLE 161 ECUADOR: NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 181 TABLE 162 ECUADOR: INFUSION PUMP DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 181 TABLE 163 ECUADOR: INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 182 TABLE 164 ECUADOR: INFUSION PUMP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 182 TABLE 165 ECUADOR: INFUSION PUMPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 182 TABLE 166 ECUADOR: INFUSION PUMPS MARKET, BY END USER, 2023–2030 (USD MILLION) 183 TABLE 167 PERU: MACROECONOMIC INDICATORS 184 TABLE 168 PERU: INFUSION PUMPS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 184 TABLE 169 PERU: INFUSION PUMP ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 184 TABLE 170 PERU: DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 185 TABLE 171 PERU: NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 185 TABLE 172 PERU: INFUSION PUMP DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 186 TABLE 173 PERU: INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 186 TABLE 174 PERU: INFUSION PUMP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 186 TABLE 175 PERU: INFUSION PUMPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 187 TABLE 176 PERU: INFUSION PUMPS MARKET, BY END USER, 2023–2030 (USD MILLION) 187 TABLE 177 REST OF LATINA AMERICA: INFUSION PUMPS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 188 TABLE 178 REST OF LATINA AMERICA: INFUSION PUMP ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 188 TABLE 179 REST OF LATINA AMERICA: DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 189 TABLE 180 REST OF LATINA AMERICA: NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 189 TABLE 181 REST OF LATINA AMERICA: INFUSION PUMP DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 190 TABLE 182 REST OF LATINA AMERICA: INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 190 TABLE 183 REST OF LATINA AMERICA: INFUSION PUMP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 191 TABLE 184 REST OF LATINA AMERICA: INFUSION PUMPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 191 TABLE 185 REST OF LATINA AMERICA: INFUSION PUMPS MARKET, BY END USER, 2023–2030 (USD MILLION) 192 TABLE 186 LATAM INFUSION PUMPS MARKET: OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS, 2022–2025 194 TABLE 187 LATAM INFUSION PUMPS MARKET: DEGREE OF COMPETITION 196 TABLE 188 LATAM INFUSION PUMPS MARKET: COUNTRY FOOTPRINT 201 TABLE 189 LATAM INFUSION PUMPS MARKET: PRODUCT FOOTPRINT 202 TABLE 190 LATAM INFUSION PUMPS MARKET: APPLICATION FOOTPRINT 203 TABLE 191 LATAM INFUSION PUMPS MARKET: DETAILED LIST OF KEY STARTUPS/SMES 206 TABLE 192 LATAM INFUSION PUMPS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 207 TABLE 193 LATAM INFUSION PUMPS MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–AUGUST 2025 210 TABLE 194 LATAM INFUSION PUMPS MARKET: DEALS, JANUARY 2022–AUGUST 2025 211 TABLE 195 LATAM INFUSION PUMPS MARKET: EXPANSIONS, JANUARY 2022–AUGUST 2025 212 TABLE 196 LATAM INFUSION PUMPS MARKET: OTHER DEVELOPMENTS, JANUARY 2022–MARCH 2025 213 TABLE 197 BD: COMPANY OVERVIEW 214 TABLE 198 BD: PRODUCTS OFFERED 215 TABLE 199 BD: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–AUGUST 2025 218 TABLE 200 BD: DEALS, JANUARY 2022–AUGUST 2025 219 TABLE 201 BD: EXPANSIONS, JANUARY 2022–AUGUST 2025 219 TABLE 202 BD: OTHER DEVELOPMENTS, JANUARY 2022–AUGUST 2025 220 TABLE 203 B. BRAUN MELSUNGEN AG: COMPANY OVERVIEW 221 TABLE 204 B. BRAUN MELSUNGEN AG: PRODUCTS OFFERED 222 TABLE 205 B. BRAUN MELSUNGEN AG: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–AUGUST 2025 227 TABLE 206 B. BRAUN MELSUNGEN AG: DEALS, JANUARY 2022–AUGUST 2025 228 TABLE 207 B. BRAUN MELSUNGEN AG: OTHER DEVELOPMENTS, JANUARY 2022–AUGUST 2025 228 TABLE 208 BAXTER INTERNATIONAL INC.: COMPANY OVERVIEW 230 TABLE 209 BAXTER INTERNATIONAL INC.: PRODUCTS OFFERED 231 TABLE 210 BAXTER INTERNATIONAL INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–AUGUST 2025 233 TABLE 211 BAXTER INTERNATIONAL INC.: DEALS, JANUARY 2022–AUGUST 2025 233 TABLE 212 BAXTER INTERNATIONAL INC.: OTHER DEVELOPMENTS, JANUARY 2022–AUGUST 2025 233 TABLE 213 FRESENIUS KABI: COMPANY OVERVIEW 235 TABLE 214 FRESENIUS KABI: PRODUCTS OFFERED 236 TABLE 215 FRESENIUS KABI: PRODUCT APPROVALS, JANUARY 2022–AUGUST 2025 239 TABLE 216 FRESENIUS KABI: DEALS, JANUARY 2022–AUGUST 2025, JANUARY 2022–AUGUST 2025 239 TABLE 217 FRESENIUS KABI: OTHER DEVELOPMENTS, JANUARY 2022–AUGUST 2025 240 TABLE 218 MEDTRONIC: COMPANY OVERVIEW 242 TABLE 219 MEDTRONIC PLC: PRODUCTS OFFERED 243 TABLE 220 MEDTRONIC PLC: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–AUGUST 2025 244 TABLE 221 MEDTRONIC: DEALS, JANUARY 2022–AUGUST 2025 245 TABLE 222 TERUMO CORPORATION: COMPANY OVERVIEW 247 TABLE 223 TERUMO CORPORATION: PRODUCTS OFFERED 248 TABLE 224 TERUMO CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–AUGUST 2025 249 TABLE 225 TERUMO CORPORATION: DEALS, JANUARY 2022–AUGUST 2025 250 TABLE 226 TERUMO CORPORATION: EXPANSIONS, JANUARY 2022–AUGUST 2025 250 TABLE 227 ICU MEDICAL, INC.: COMPANY OVERVIEW 251 TABLE 228 ICU MEDICAL, INC.: PRODUCTS OFFERED 252 TABLE 229 ICU MEDICAL, INC.: PRODUCT APPROVALS, JANUARY 2022–AUGUST 2025 254 TABLE 230 ICU MEDICAL, INC.: DEALS, JANUARY 2022–AUGUST 2025 254 TABLE 231 ICU MEDICAL, INC.: OTHER DEVELOPMENTS 254 TABLE 232 AVANOS MEDICAL, INC.: COMPANY OVERVIEW 255 TABLE 233 AVANOS MEDICAL, INC.: PRODUCTS OFFERED 256 TABLE 234 NIPRO CORPORATION: COMPANY OVERVIEW 258 TABLE 235 NIPRO CORPORATION: PRODUCTS OFFERED 259 TABLE 236 NIPRO CORPORATION: EXPANSIONS, JANUARY 2022–AUGUST 2025 260 TABLE 237 JMS CO., LTD.: COMPANY OVERVIEW 261 TABLE 238 JMS CO., LTD.: PRODUCTS OFFERED 263 TABLE 239 CARDINAL HEALTH, INC.: COMPANY OVERVIEW 264 TABLE 240 CARDINAL HEALTH, INC.: PRODUCTS OFFERED 266 TABLE 241 ROCHE DIAGNOSTICS: COMPANY OVERVIEW 267 TABLE 242 ROCHE DIAGNOSTICS: PRODUCTS OFFERED 269 TABLE 243 ROCHE DIAGNOSTICS: EXPANSIONS, JANUARY 2022–AUGUST 2025 269 TABLE 244 ABBOTT LABORATORIES: COMPANY OVERVIEW 270 TABLE 245 ABBOTT LABORATORIES: PRODUCTS OFFERED 271 TABLE 246 DANAHER CORPORATION: COMPANY OVERVIEW 272 TABLE 247 DANAHER CORPORATION: PRODUCTS OFFERED 274 TABLE 248 YPSOMED AG: COMPANY OVERVIEW 275 TABLE 249 YPSOMED AG: PRODUCTS OFFERED 276 TABLE 250 TANDEM DIABETES CARE, INC.: COMPANY OVERVIEW 277 TABLE 251 HARVARD BIOSCIENCE INC.: COMPANY OVERVIEW 278 TABLE 252 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY OVERVIEW 279 TABLE 253 INTUVIE HOLDINGS LLC: COMPANY OVERVIEW 280 TABLE 254 ANGIPLAST PVT. LTD.: COMPANY OVERVIEW 281 TABLE 255 IRADIMED CORPORATION: COMPANY OVERVIEW 282 TABLE 256 NEW ERA INSTRUMENTS: COMPANY OVERVIEW 283 TABLE 257 EPIC MEDICAL: COMPANY OVERVIEW 284 TABLE 258 SHENZHEN MEDRENA BIOTECH CO., LTD.: COMPANY OVERVIEW 285 TABLE 259 CODAN COMPANIES: COMPANY OVERVIEW 285 FIGURE 1 LATAM INFUSION PUMPS MARKET & COUNTRY SEGMENTATION 27 FIGURE 2 RESEARCH DESIGN 31 FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 34 FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 35 FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2024) 36 FIGURE 6 LATAM INFUSION PUMPS MARKET: SUPPLY-SIDE ANALYSIS 37 FIGURE 7 TOP-DOWN APPROACH 38 FIGURE 8 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF LATAM INFUSION PUMPS MARKET, 2025–2030 39 FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS OF LATAM INFUSION PUMPS MARKET (2025–2030) 40 FIGURE 10 DATA TRIANGULATION METHODOLOGY 41 FIGURE 11 KEY INDUSTRY INSIGHTS 42 FIGURE 12 LATAM INFUSION PUMPS MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION) 44 FIGURE 13 LATAM INFUSION PUMP ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 45 FIGURE 14 LATAM INFUSION PUMP DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 46 FIGURE 15 LATAM INFUSION PUMP NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 47 FIGURE 16 LATAM INFUSION PUMP DEVICES MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION) 48 FIGURE 17 LATAM INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION) 48 FIGURE 18 LATAM INFUSION PUMP DEVICES MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 49 FIGURE 19 LATAM INFUSION PUMPS MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION) 50 FIGURE 20 LATAM INFUSION PUMPS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 51 FIGURE 21 GEOGRAPHIC SNAPSHOT: LATAM INFUSION PUMPS MARKET 52 FIGURE 22 INCREASING INCIDENCE OF CHRONIC DISEASES TO PROPEL MARKET 53 FIGURE 23 ACCESSORIES & CONSUMABLES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN BRAZIL IN 2024 54 FIGURE 24 DEVELOPED COUNTRIES TO GROW AT HIGHER GROWTH RATES DURING FORECAST PERIOD 55 FIGURE 25 COLOMBIA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 55 FIGURE 26 LATAM INFUSION PUMPS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 56 FIGURE 27 PEOPLE WITH DIABETES (20–79 YEARS), BY COUNTRY, 2021 VS. 2045 (IN THOUSANDS) 57 FIGURE 28 LATAM INFUSION PUMPS MARKET: PORTER’S FIVE FORCES ANALYSIS 65 FIGURE 29 LATAM INFUSION PUMPS MARKET: NUMBER OF GRANTED PATENT APPLICATIONS (JANUARY 2014–AUGUST 2025) 71 FIGURE 30 TOP APPLICANT COUNTRIES/REGIONS FOR INFUSION PUMPS PATENTS (JANUARY 2014–AUGUST 2025) 72 FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR INFUSION PUMPS 77 FIGURE 32 KEY BUYING CRITERIA FOR INFUSION PUMPS, BY TOP 3 END USERS 78 FIGURE 33 LATAM INFUSION PUMPS MARKET: ECOSYSTEM ANALYSIS 80 FIGURE 34 LATAM INFUSION PUMPS MARKET: VALUE CHAIN ANALYSIS 81 FIGURE 35 REVENUE SHIFTS & NEW REVENUE POCKETS FOR LATAM INFUSION PUMPS MARKET 82 FIGURE 36 LATAM INFUSION PUMPS MARKET SNAPSHOT 152 FIGURE 37 LATAM INFUSION PUMPS MARKET: REVENUE ANALYSIS OF TOP FIVE PLAYERS, 2022–2024 195 FIGURE 38 MARKET SHARE ANALYSIS, 2024 196 FIGURE 39 LATAM INFUSION PUMPS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS, 2024 199 FIGURE 40 LATAM INFUSION PUMPS MARKET: COMPANY FOOTPRINT 200 FIGURE 41 LATAM INFUSION PUMPS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 205 FIGURE 42 R&D EXPENDITURE OF KEY PLAYERS IN LATAM INFUSION PUMPS MARKET, 2022–2024 208 FIGURE 43 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 208 FIGURE 44 EV/EBITDA OF KEY VENDORS 209 FIGURE 45 LATAM INFUSION PUMPS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 209 FIGURE 46 BD: COMPANY SNAPSHOT (2024) 215 FIGURE 47 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2024) 222 FIGURE 48 BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT (2024) 231 FIGURE 49 FRESENIUS KABI: COMPANY SNAPSHOT (2024) 236 FIGURE 50 MEDTRONIC: COMPANY SNAPSHOT (2024) 243 FIGURE 51 TERUMO CORPORATION: COMPANY SNAPSHOT (2024) 248 FIGURE 52 ICU MEDICAL, INC.: COMPANY SNAPSHOT (2024) 252 FIGURE 53 AVANOS MEDICAL, INC.: COMPANY SNAPSHOT (2024) 256 FIGURE 54 NIPRO CORPORATION: COMPANY SNAPSHOT (2024) 259 FIGURE 55 JMS CO., LTD.: COMPANY SNAPSHOT (2024) 262 FIGURE 56 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT (2024) 265 FIGURE 57 ROCHE DIAGNOSTICS.: COMPANY SNAPSHOT (2024) 268 FIGURE 58 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2024) 271 FIGURE 59 DANAHER CORPORATION: COMPANY SNAPSHOT (2024) 273 FIGURE 60 YPSOMED AG: COMPANY SNAPSHOT (2024) 276

同分類最新報告（醫療器材）

查看醫療器材全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們